FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Kennedy Jonathan		 2. Issuer Name and Ticker or Trading Symbol

NATUS MEDICAL INC [ NTUS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
President and CEO
(Last)          (First)          (Middle)

C/O NATUS MEDICAL INCORPORATED, 6701 KOLL CENTER PARKWAY, SUITE 120		 3. Date of Earliest Transaction (MM/DD/YYYY)

11/4/2019
(Street)

PLEASANTON, CA 94566
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.001 par value per share  11/4/2019  11/4/2019  M    5000  A $22.50  144517  D   
Common Stock, $0.001 par value per share  11/4/2019  11/4/2019  S    4408  D $33.65 (1) 140109  D   
Common Stock, $0.001 par value per share  11/5/2019  11/5/2019  M    5000  A $22.50  145109  D   
Common Stock, $0.001 par value per share  11/5/2019  11/5/2019  S    4268  D $34.32 (2) 140841  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified Stock Option  $22.5  11/4/2019    M        4408   2/1/2014  1/1/2020  Common Stock  4408.0  $0  592  D   
Non-qualified Stock Option  $22.5  11/5/2019    M        4268   2/1/2014  1/1/2020  Common Stock  4268.0  $0  1324  D   

Explanation of Responses:
(1)  1.This transaction was executed in multiple trades a prices ranging from $33.59 to $33.85. The price reflected above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(2)  1.This transaction was executed in multiple trades a prices ranging from $34.30 to $34.33. The price reflected above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Kennedy Jonathan
C/O NATUS MEDICAL INCORPORATED
6701 KOLL CENTER PARKWAY, SUITE 120
PLEASANTON, CA 94566 		X
President and CEO

Signatures
/s/ WILLIAM B. HILL by POWER BY ATTORNEY 11/6/2019
**Signature of Reporting Person Date


PishPosh (NASDAQ:BABY)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more PishPosh Charts.
PishPosh (NASDAQ:BABY)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more PishPosh Charts.
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....